Creative Planning’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-143,377
| Closed | -$12.2M | – | 2519 |
|
|
2020
Q3 | $12.2M | Sell |
143,377
-6,982
| -5% | -$353K | 0.03% | 183 |
|
|
2020
Q2 | $5.33M | Sell |
150,359
-12,016
| -7% | -$351K | 0.02% | 278 |
|
|
2020
Q1 | $2.19M | Sell |
162,375
-99,080
| -38% | -$1.67M | 0.01% | 405 |
|
|
2019
Q4 | $5.53M | Hold |
261,455
| – | – | 0.02% | 279 |
|
|
2019
Q3 | $3.47M | Buy |
261,455
+18,927
| +8% | +$278K | 0.01% | 360 |
|
|
2019
Q2 | $3.36M | Buy |
242,528
+8,672
| +4% | +$130K | 0.01% | 366 |
|
|
2019
Q1 | $4.49M | Buy |
233,856
+14,135
| +6% | +$228K | 0.02% | 293 |
|
|
2018
Q4 | $3.13M | Buy |
219,721
+2,658
| +1% | +$52.8K | 0.01% | 335 |
|
|
2018
Q3 | $4.52M | Buy |
217,063
+822
| +0.4% | +$19.5K | 0.02% | 293 |
|
|
2018
Q2 | $5.12M | Buy |
216,241
+11,460
| +6% | +$230K | 0.02% | 250 |
|
|
2018
Q1 | $2.99M | Sell |
204,781
-8,514
| -4% | -$139K | 0.01% | 366 |
|
|
2017
Q4 | $3.45M | Sell |
213,295
-1,658,552
| -89% | -$19.6M | 0.01% | 323 |
|
|
2017
Q3 | $26.2M | Buy |
1,871,847
+1,692,717
| +945% | +$16.9M | 0.12% | 78 |
|
|
2017
Q2 | $1.58M | Buy |
179,130
+3,065
| +2% | +$21.5K | 0.01% | 515 |
|
|
2017
Q1 | $1.14M | Buy |
176,065
+109,200
| +163% | +$553K | 0.01% | 612 |
|
|
2016
Q4 | $245K | Buy |
66,865
+8,380
| +14% | +$24.8K | ﹤0.01% | 1300 |
|
|
2016
Q3 | $190K | Hold |
58,485
| – | – | ﹤0.01% | 1432 |
|
|
2016
Q2 | $136K | Buy |
58,485
+510
| +0.9% | +$1.7K | ﹤0.01% | 1475 |
|
|
2016
Q1 | $145K | Sell |
57,975
-14,000
| -19% | -$31.5K | ﹤0.01% | 1400 |
|
|
2015
Q4 | $221K | Buy |
71,975
+35,000
| +95% | +$97.7K | ﹤0.01% | 1146 |
|
|
2015
Q3 | $64K | Buy |
36,975
+175
| +0.5% | +$447 | ﹤0.01% | 1874 |
|
|
2015
Q2 | $149K | Buy |
36,800
+2,000
| +6% | +$8.18K | ﹤0.01% | 929 |
|
|
2015
Q1 | $133K | Buy |
34,800
+4,000
| +13% | +$17.4K | ﹤0.01% | 1419 |
|
|
2014
Q4 | $148K | Buy |
30,800
+500
| +2% | +$1.98K | ﹤0.01% | 1315 |
|
|
2014
Q3 | $113K | Buy |
30,300
+1,000
| +3% | +$3.38K | ﹤0.01% | 1396 |
|
|
2014
Q2 | $107K | Buy |
29,300
+2,710
| +10% | +$9.95K | ﹤0.01% | 1393 |
|
|
2014
Q1 | $112K | Buy |
26,590
+21,300
| +403% | +$106K | ﹤0.01% | 1340 |
|
|
2013
Q4 | $24K | Hold |
5,290
| – | – | ﹤0.01% | 2085 |
|
|
2013
Q3 | $33K | Hold |
5,290
| – | – | ﹤0.01% | 1784 |
|
|
2013
Q2 | $29K | Buy |
+5,290
| New | +$17.4K | ﹤0.01% | 1703 |
|
Creative Planning's IMMU Position: Q4 2020 in Review
Creative Planning sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 143,377 shares — an estimated $12.2M sold.
Creative Planning first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $26.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Creative Planning reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Creative Planning sold 143,377 Immunomedics Inc shares in Q4 2020, an estimated $12.2M.
- Creative Planning first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Creative Planning's Immunomedics Inc position peaked at $26.2M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Creative Planning's 13F filing for Q4 2020, filed 29 Jan 2021.